美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

阿库拉制药

0.0200

0.0000

成交量：- -

成交额：- -

市值：132.70万

市盈率：-1.00

高：0.0200

开：0.0200

低：0.0200

收：0.0200

数据加载中...

总览公司新闻公告

公司资料

公司名字：

阿库拉制药

交易所：

EXPERT

成立时间：

1935

员工人数：

- -

公司地址：

616 N. North Court,Suite 120,Palatine,Illinois,United States

官网：

http://www.acurapharm.com

邮编：

60067

电话：

传真：

847 705 5399

简介：

Acura Pharmaceuticals, Inc.是一家纽约公司，其子公司是一家专业制药公司，从事产品和技术的研究、开发和商业化，旨在解决药物滥用和误用。该公司已经研发了两项专利技术。公司的反感技术（Aversion Technology）是将惰性成分的混合物用于药片和胶囊，旨在解决一些常见的类鸦片药物的滥用。 Pfizer控股公司的盐酸羟考酮片是首个被批准销售的利用反感技术制成的药品，是公司与 Pfizer的子公司签订协议后合作开发的。该公司还开发了结合非活性成分的阻碍技术,防止从药片中提取伪麻黄碱，防止伪麻黄碱直接转换成冰毒。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ACUR/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACUR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUR\",,,,,undefined,":{"symbol":"ACUR","market":"US","secType":"STK","nameCN":"阿库拉制药","latestPrice":0.02,"timestamp":1747325460000,"preClose":0.02,"halted":0,"volume":0,"delay":15,"floatShares":9990324,"shares":66349283,"eps":-0.02,"marketStatus":"交易中","change":0,"latestTime":"05-15 12:11:00 EDT 延时","open":0.02,"high":0.02,"low":0.02,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.02,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1747339200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.02,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACUR\",,,,,undefined,":{"symbol":"ACUR","floatShares":9990324,"roa":"-58.46%","roe":"15.24%","lyrEps":-0.015475,"shares":66349283,"dividePrice":0,"high":0.02,"amplitude":0,"preClose":0.02,"low":0.02,"week52Low":0.0002,"pbRate":"7.45","psRate":"0.85","week52High":0.7532,"institutionHeld":0,"latestPrice":0.02,"eps":-0.02,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.02,"open":0.02,"prevYearClose":0.0002,"prevWeekClose":0.02,"prevMonthClose":0.0198,"prevQuarterClose":0.0198,"fiveDayClose":0.02,"twentyDayClose":0.0198,"sixtyDayClose":0.0066},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":29262,"yearFounded":1935,"address":"616 N. North Court,Suite 120,Palatine,Illinois,United States","zipCode":"60067","officePhone":"847 705 7709","officeFax":"847 705 5399"},"stockCompanyDetail":{"websiteUrl":"http://www.acurapharm.com","stockEarnings":[{"period":"1week","weight":-0.1892},{"period":"1month","weight":0},{"period":"3month","weight":0.4925},{"period":"6month","weight":0.6575},{"period":"1year","weight":0.0345},{"period":"ytd","weight":1.611}],"description":"Acura Pharmaceuticals, Inc.是一家纽约公司，其子公司是一家专业制药公司，从事产品和技术的研究、开发和商业化，旨在解决药物滥用和误用。该公司已经研发了两项专利技术。公司的反感技术 （Aversion Technology） 是将惰性成分的混合物用于药片和胶囊，旨在解决一些常见的类鸦片药物的滥用。 Pfizer控股公司的盐酸羟考酮片是首个被批准销售的利用反感技术制成的药品，是公司与 Pfizer的子公司签订协议后合作开发的。该公司还开发了结合非活性成分的阻碍技术,防止从药片中提取伪麻黄碱，防止伪麻黄碱直接转换成冰毒。","exchange":"EXPERT","name":"阿库拉制药","nameEN":"Acura Pharmaceuticals, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ACUR\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACUR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-05-17","symbol":"ACUR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1621224000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2021-03-31","symbol":"ACUR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1617163200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2020-11-16","symbol":"ACUR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1605502800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2020-06-29","symbol":"ACUR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1593403200000,"reportTimeType":"post","actualEps":null},{"date":"2020-06-15","symbol":"ACUR","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1592251200000,"name":null,"time":"盘后","dateTimestamp":1592193600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACUR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACUR\",market:\"US\",delay:false,,,undefined,":{}}}